4:47 PM
 | 
Jul 19, 2007
 |  BC Extra  |  Top Story

Tysabri gets negative CHMP opinion

EMEA's CHMP issued a negative opinion on an MAA for Tysabri natalizumab from Elan (ELN) and Biogen Idec (BIIB) to treat moderate to severe...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >